Insider Transactions in Q3 2021 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,292
-0.07%
|
$61,884
$27.0 P/Share
|
|
Sep 30
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,292
-0.07%
|
$61,884
$27.0 P/Share
|
|
Sep 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,836
-0.07%
|
$103,572
$27.0 P/Share
|
|
Sep 28
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,214
-0.58%
|
$518,778
$27.0 P/Share
|
|
Sep 28
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,214
-0.58%
|
$518,778
$27.0 P/Share
|
|
Sep 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,154
-0.59%
|
$868,158
$27.0 P/Share
|
|
Sep 27
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,625
-0.35%
|
$313,875
$27.09 P/Share
|
|
Sep 27
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,625
-0.35%
|
$313,875
$27.09 P/Share
|
|
Sep 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,455
-0.36%
|
$525,285
$27.09 P/Share
|
|
Sep 24
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,913
-0.15%
|
$132,651
$27.81 P/Share
|
|
Sep 24
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,913
-0.15%
|
$132,651
$27.81 P/Share
|
|
Sep 24
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,089
-1.09%
|
$30,492
$28.02 P/Share
|
|
Sep 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,221
-0.15%
|
$221,967
$27.81 P/Share
|
|
Sep 23
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,930
-0.55%
|
$1,034,040
$28.17 P/Share
|
|
Sep 23
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,930
-0.55%
|
$1,034,040
$28.17 P/Share
|
|
Sep 23
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,322
-5.05%
|
$149,016
$28.16 P/Share
|
|
Sep 23
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
61,800
-0.56%
|
$1,730,400
$28.17 P/Share
|
|
Sep 22
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,294
-0.42%
|
$385,938
$27.54 P/Share
|
|
Sep 22
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,294
-0.42%
|
$385,938
$27.54 P/Share
|
|
Sep 22
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,921
-0.43%
|
$645,867
$27.54 P/Share
|
|
Sep 21
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,635
-0.58%
|
$530,145
$27.47 P/Share
|
|
Sep 21
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,635
-0.58%
|
$530,145
$27.47 P/Share
|
|
Sep 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,858
-0.59%
|
$887,166
$27.47 P/Share
|
|
Sep 20
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,303
-0.36%
|
$656,181
$27.44 P/Share
|
|
Sep 20
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,303
-0.36%
|
$656,181
$27.44 P/Share
|
|
Sep 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,673
-0.36%
|
$1,098,171
$27.44 P/Share
|
|
Sep 17
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,698
-1.32%
|
$1,279,544
$28.82 P/Share
|
|
Sep 17
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,698
-1.32%
|
$1,279,544
$28.82 P/Share
|
|
Sep 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
76,473
-1.34%
|
$2,141,244
$28.82 P/Share
|
|
Sep 16
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,253
-0.61%
|
$595,084
$28.47 P/Share
|
|
Sep 16
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,253
-0.61%
|
$595,084
$28.47 P/Share
|
|
Sep 16
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,565
-0.62%
|
$995,820
$28.47 P/Share
|
|
Sep 15
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,104
-0.34%
|
$650,808
$27.97 P/Share
|
|
Sep 15
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,104
-0.34%
|
$650,808
$27.97 P/Share
|
|
Sep 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,336
-0.35%
|
$1,089,072
$27.97 P/Share
|
|
Sep 14
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,561
-0.31%
|
$582,147
$27.75 P/Share
|
|
Sep 14
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,561
-0.31%
|
$582,147
$27.75 P/Share
|
|
Sep 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,081
-0.31%
|
$974,187
$27.75 P/Share
|
|
Sep 13
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,384
-0.6%
|
$577,368
$27.64 P/Share
|
|
Sep 13
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,384
-0.6%
|
$577,368
$27.64 P/Share
|
|
Sep 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,785
-0.61%
|
$966,195
$27.64 P/Share
|
|
Sep 10
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,531
-0.19%
|
$378,868
$28.3 P/Share
|
|
Sep 10
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,531
-0.19%
|
$378,868
$28.3 P/Share
|
|
Sep 10
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,643
-0.19%
|
$634,004
$28.3 P/Share
|
|
Sep 09
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,725
-0.63%
|
$636,300
$28.97 P/Share
|
|
Sep 09
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,725
-0.63%
|
$636,300
$28.97 P/Share
|
|
Sep 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,028
-0.64%
|
$1,064,784
$28.97 P/Share
|
|
Sep 08
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,092
-0.17%
|
$338,576
$28.86 P/Share
|
|
Sep 08
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,092
-0.17%
|
$338,576
$28.86 P/Share
|
|
Sep 08
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,236
-0.17%
|
$566,608
$28.86 P/Share
|